Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993309014 | Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3993310016 | Human tetanus immunoglobulin 250 international unit/mL solution for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | immunoglobuline antitétanique humaine | true | Inferred relationship | Some | 1 | |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | immunoglobuline antitétanique humaine | true | Inferred relationship | Some | 1 | |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator value (attribute) | 250 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | international unit (qualifier value) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| HyperTET 250 antitoxin units per milliliter solution for injection Grifols Canada Limited (real clinical drug) | est un(e) (attribut) | True | Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR